US trade body welcomes Indian move on FDI in pharma

Washington, Dec 5 : The US-India Business Council (USIBC) has welcomed the Indian government's decision to reject a proposal limiting pharmaceutical investment caps to 49 percent in the brownfield investment sector.

"Such a reversal would have sent chilling signals to investors, chased capital to other markets, and prevented domestic companies from growing and collaborating," the trade advocacy group comprising over 350 top-tier US and Indian companies said Wednesday.

"Instead, the decision by the Government of India reassures investors that India is not going back on reforms," the group said.

The announcement will encourage competition and investment in the pharmaceutical sector which will continue to create jobs and ensure that patients receive access to important medicines, it said.

"In our global environment where competition for capital is significant, India's recent announcement to continue to allow investment in the pharmaceutical sector up to 100 percent is a powerful signal that its market reforms remain intact and that India's reform direction is clear," said USIBC President Ron Somers.

"USIBC continues our commitment to working with the Government of India to deepen the US-India trade relationship and the rejection of such a harmful proposal demonstrates that India remains a top investment destination," he said.

--IANS (Posted on 05-12-2013)

pharmaceutical-news headlines

Sanofi appoints N Rajaram as Country Head & GM (Pharma operations)

Nutraceuticals slams FSSAI 'Product Approval' scheme

Some facts about drug over which Powell banned

Lupin gets USFDA nod for diabetes management drug

Sun Pharma to acquire Ranbaxy for USD four billion in all stock transaction

Sun Pharma to buy Ranbaxy for $4 billion in all-share deal

Venus gets marketing nod from Venezuela for meropenem

Venus gets marketing nod from Venezuela for infection drug

Jubilant Life to develop new drugs to combat TB

Jubilant gets $3.4 mn for new anti-TB drugs

Prolonged crisis in Ukraine could affect Indian pharma companies

Strand receives US patent for virtual liver

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014


Your e-mail:

Your Full Name:

Type verification image:
verification image, type it in the box


Back to Top